Your browser doesn't support javascript.
loading
Thromboprophylaxis in lower limb varicose vein surgery in Brazil.
Ribeiro, Alcides José Araújo; Mendes-Pinto, Daniel; Erzinger, Fabiano Luiz; Fiorelli, Rossano Kepler Alvim; Fiorelli, Stênio Karlos Alvim; Ribeiro, Andrea Campos de Oliveira; Marques, Marcos Arêas.
Afiliação
  • Ribeiro AJA; Hospital de Base do Distrito Federal, Brasília, DF, Brasil.
  • Mendes-Pinto D; Hospital Felício Rocho, Belo Horizonte, MG, Brasil.
  • Erzinger FL; Hospital Erasto Gaertner, Curitiba, PR, Brasil.
  • Fiorelli RKA; Universidade Federal do Estado do Rio de Janeiro - UNIRIO, Rio de Janeiro, RJ, Brasil.
  • Fiorelli SKA; Universidade Federal do Estado do Rio de Janeiro - UNIRIO, Rio de Janeiro, RJ, Brasil.
  • Ribeiro ACO; Clínica Villas Boas, DF, Brasília, Brasil.
  • Marques MA; Universidade Federal do Estado do Rio de Janeiro - UNIRIO, Rio de Janeiro, RJ, Brasil.
J Vasc Bras ; 21: e20210172, 2022.
Article em En | MEDLINE | ID: mdl-35677747
Background: Despite all the investment in primary venous thromboembolism (VTE) prophylaxis for surgical patients in recent years, there are still no specific guidelines for those who undergo procedures to treat lower limb varicose veins. Objectives: To evaluate the profile of VTE prophylaxis practices among Brazilian vascular surgeons conducting lower limb varicose vein procedures. Methods: Survey design, sending an electronic questionnaire to Brazilian vascular surgeons. Respondents were divided between those who perform saphenous vein treatment with conventional surgery and those who perform thermoablation for the purpose of comparison between groups. Results: Of 765 respondents, 405 (53%) treat saphenous veins with conventional surgery for, 44 (6%) with foam, and 199 (26%) with thermoablation (endolaser or radiofrequency). Surgeons who perform thermoablation prescribed more pharmacoprophylaxis after varicose vein surgery than those who perform conventional surgery (67/199, 34% vs. 112/405, 28%; p = 0.002). The thermoablation group stratifies patients for thromboembolism risk more frequently than the conventional surgery group (102/199, 51% vs. 179/405, 44%; p = 0.004). Both groups use enoxaparin as the most frequent drug for prophylaxis, but the thermoablation group uses proportionally more direct oral anticoagulants than the conventional surgery group (26% vs. 10%, p<0.001). Conclusions: Brazilian vascular surgeons who perform saphenous vein treatment by thermoablation prescribe pharmacoprophylaxis more frequently and for a longer period than those who use conventional surgery.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Vasc Bras Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Qualitative_research País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Vasc Bras Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil